U.S. federal trademark · Serial No. 99800540
Pharmaceutical preparations for the treatment of genetic diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, and immune system disorders, delivered using a delivery technology
Research and development services in the fields of nucleic acid therapeutics and ribonucleic acid (RNA) medicine, namely, development of programmable messenger ribonucleic acid (mRNA) and oligonucleotide-based delivery platforms for use in therapeutic applications; scientific consultation in the field of targeted RNA delivery
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.